Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.07 USD | -0.01% | +0.30% | +7.67% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.67% | 3.42B | |
-4.78% | 11.52B | |
-4.86% | 8.3B | |
+39.44% | 5.73B | |
-21.87% | 4.69B | |
-19.10% | 2.54B | |
-13.36% | 2.03B | |
-16.39% | 1.86B | |
-31.24% | 1.59B | |
-8.57% | 1.17B |
- Stock Market
- Equities
- AXNX Stock
- News Axonics, Inc.
- Transcript : Axonics, Inc. Presents at Bank of America Securities 2023 Healthcare Conference, May-09-2023 11